Henryschein Dental Company (HSIC)

Dental and medical products company Henry Schein (NASDAQ:HSIC) met Wall Street’s revenue expectations in Q3 2026, with revenue up 4% year on year to $3.47 bi...

Dental and medical products company Henry Schein (NASDAQ:HSIC) will be reporting earnings this Tuesday before market hours. Here’s what you need to know. Hen...

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how dental equipment & tec...

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on hi...

Henry Schein trades at $86.39 and has moved in lockstep with the market. Its shares have returned 18.8% over the last six months while the S&P 500 has gained...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...

Cloud-based dental software drives margin expansion and record customer growth.

Henry Schein delivered a positive second quarter, with results exceeding Wall Street’s expectations and earning a strong market response. Management attribut...

Dental and medical products company Henry Schein (NASDAQ:HSIC) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 6.7% year on ...

What Happened? Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) jumped 2.8% in the afternoon session after the company reported secon...

Henry Schein (NASDAQ:HSIC) reported higher second-quarter sales, operating margins and earnings, citing accelerating internal sales growth, market-share gains in dental merchandise and early benefits from its value-creation program. The company also raised its full-year sales and adjusted earnings g

Henry Schein (NASDAQ:HSIC) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by Benzinga

Dental and medical products company Henry Schein (NASDAQ:HSIC) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 6.7% year ...

Dental and medical products company Henry Schein (NASDAQ:HSIC) will be reporting results this Tuesday before the bell. Here’s what you need to know. Henry Sc...

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the dental equipment & technology stocks, including Henry Schein (NASDAQ:HSIC) and its ...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...